Original Research and the Latest News

How Next-Generation Probability of Success Forecasting Can Improve Clinical Trial Accuracy by 44%

by | January 16, 2026 | New Technology, Probability of Success | 0 Comments

Unlocking Next-Gen POS Forecasting for Biopharma Success In the high-stakes world of biopharma, advanced Probability of Success (POS) forecasting can revolutionize the landscape of clinical trials. By adopting next-gen POS forecasting models, companies can...

Not Your Grandparents’ Probability of Success Forecasts

by | November 9, 2025 | New Technology, Probability of Success | 0 Comments

Redefining Probability of Success in Pharma: A Data-Driven Revolution In the world of pharmaceutical strategic planning and analytics, traditional Probability of Success (POS) forecasts are a familiar, yet often frustrating approach to assessing clinical risk. While...

Who’s Winning the Pharmaceutical R&D Pipeline Race in 2025

by | October 26, 2025 | Business, Data Analytics, Industry Trends, Market Scan, New Technology, Probability of Success | 0 Comments

The leaders, the contenders, and the strategies for success As we approach the 4th quarter of 2025, let’s review where the pharmaceutical industry’s leading companies rank in terms of overall pipeline strength.Roche, AstraZeneca, and Bristol-Myers Squibb sit in a...

Clinical Trial Success Rates: What Makes Some Companies Stand Out?

by | October 9, 2025 | New Technology, Probability of Success | 0 Comments

Our comprehensive analysis of over 30,000 clinical trials across more than 4,000 biopharmaceutical companies reveals significant variations in clinical trial success rates. This disparity exists even among trials in the same phase and targeting the same disease,...

Recent Posts

We’re Back!

Oct 27, 2017 |

Ozmosi has been on a purpose-driven hiatus peppered with innovation, development and growth. In less than one year, we have...

Recent Tweets

Ozmosi Follow

BioPharma/Biotech Intel. Daily $XBI $XPH Market Movers Database: https://t.co/IBOqbSoYuc Clinical trial tools: https://t.co/A77u9Q84Dc https://t.co/AQERg9nHrb

OzmosiHealth
ozmosihealth Ozmosi @ozmosihealth ·
3 Apr

$DNLI

Denali Therapeutics Regains Full Rights to Investigational Therapy DNL593 (PTV:PGRN) for GRN-related Frontotemporal Dementia (FTD-GRN)

More Info: https://pryzm.ozmosi.com/product/25257

Reply on Twitter 2040173016060150062 Retweet on Twitter 2040173016060150062 1 Like on Twitter 2040173016060150062 2 Twitter 2040173016060150062
ozmosihealth Ozmosi @ozmosihealth ·
3 Apr

$SNGX Soligenix presented P3 T-Cell Cutaneous Lymphoma results on 2026-04-02 for Racepericin

More Info: https://pryzm.ozmosi.com/product/18781

Reply on Twitter 2040132285157319085 Retweet on Twitter 2040132285157319085 Like on Twitter 2040132285157319085 Twitter 2040132285157319085
ozmosihealth Ozmosi @ozmosihealth ·
3 Apr

$PRTC PureTech presented P1 Healthy Volunteers results on 2026-04-02 for SPT-320

More Info: https://pryzm.ozmosi.com/product/37570

Reply on Twitter 2040132280178655561 Retweet on Twitter 2040132280178655561 Like on Twitter 2040132280178655561 Twitter 2040132280178655561
ozmosihealth Ozmosi @ozmosihealth ·
3 Apr

$ROIV Roivant Sciences presented P3 Thyroid Eye Disease results on 2026-04-02 for Batoclimab

More Info: https://pryzm.ozmosi.com/product/20684

Reply on Twitter 2040132282527441168 Retweet on Twitter 2040132282527441168 Like on Twitter 2040132282527441168 Twitter 2040132282527441168
Load More

Get Started with OZMOSI

We synthesize and process insights, delivering what you need quickly, effectively, and efficiently.

Get in Touch

info@ozmosi.com
(732) 701-7807

600 Warren Ave,
Spring Lake, NJ 07762